349 related articles for article (PubMed ID: 20173336)
1. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
Paquet D; Schmid B; Haass C
Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
[TBL] [Abstract][Full Text] [Related]
2. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish.
van Bebber F; Paquet D; Hruscha A; Schmid B; Haass C
Neurobiol Dis; 2010 Sep; 39(3):265-71. PubMed ID: 20381619
[TBL] [Abstract][Full Text] [Related]
4. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
5. Modulation of tau pathology in tau transgenic models.
Brion JP; Ando K; Heraud C; Leroy K
Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992
[TBL] [Abstract][Full Text] [Related]
6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
7. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
8. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
9. Anatamopathological spectrum of tauopathies.
Revesz T; Holton JL
Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
[TBL] [Abstract][Full Text] [Related]
10. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
11. Brief update on different roles of tau in neurodegeneration.
Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
[TBL] [Abstract][Full Text] [Related]
12. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
13. [Animal models of tauopathies].
Higuchi M
Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
[TBL] [Abstract][Full Text] [Related]
14. Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.
Cowan CM; Chee F; Shepherd D; Mudher A
Biochem Soc Trans; 2010 Apr; 38(2):564-70. PubMed ID: 20298222
[TBL] [Abstract][Full Text] [Related]
15. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
[TBL] [Abstract][Full Text] [Related]
16. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation.
Paquet D; Bhat R; Sydow A; Mandelkow EM; Berg S; Hellberg S; Fälting J; Distel M; Köster RW; Schmid B; Haass C
J Clin Invest; 2009 May; 119(5):1382-95. PubMed ID: 19363289
[TBL] [Abstract][Full Text] [Related]
17. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
Williams DR
Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
[TBL] [Abstract][Full Text] [Related]
18. [Tau story: from frontotemporal dementia to other tauopathies].
Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A
J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624
[TBL] [Abstract][Full Text] [Related]
19. From tau phosphorylation to tau aggregation: what about neuronal death?
Buée L; Troquier L; Burnouf S; Belarbi K; Van der Jeugd A; Ahmed T; Fernandez-Gomez F; Caillierez R; Grosjean ME; Begard S; Barbot B; Demeyer D; Obriot H; Brion I; Buée-Scherrer V; Maurage CA; Balschun D; D'hooge R; Hamdane M; Blum D; Sergeant N
Biochem Soc Trans; 2010 Aug; 38(4):967-72. PubMed ID: 20658986
[TBL] [Abstract][Full Text] [Related]
20. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML
Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]